earnings
confidence high
sentiment positive
materiality 0.85
908 Devices Q1 rev +14% to $13.4M, raises FY26 outlook; buys NIRLAB for $15M
908 Devices Inc.
2026-Q1 EPS reported
-$0.32
revenue$13,381,000
- Q1 revenue $13.4M (+14% YoY); recurring revenue $4.0M (30% of total); gross margin 51%, adj. 57%.
- Net loss from cont. ops $12.0M; adj. EBITDA loss $2.5M vs $4.6M loss a year ago; cash $111.7M, no debt.
- FY2026 revenue guidance raised to $67-70M (19-25% growth); installed base 3,903 devices (+23% YoY).
- Completed acquisition of NIRLAB AG for $15M ($13M cash + $2M stock) plus up to $8M earn-out in stock.
- NIRLAB adds NIR spectroscopy for narcotics; over 1M analyses; expands international and subscription revenue.
item 1.01item 2.01item 2.02item 3.02item 7.01item 9.01